Cell Therapy Market by Cell Type (Stem Cell and Non-Stem Cell), Therapy Type (Autologous and Allogenic), Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), and End User (Hospitals & Clinics and Acade

Cell Therapy Market

The global cell therapy market accounted for USD 7,754.89 Million in 2019, and is expected to reach USD 48,115.40 Million by 2027, registering a CAGR of 25.6% from 2020 to 2027. Rise in prevalence of population suffering from cardiovascular, cancer, and other diseases is expected to positively affect growth of the market.

Download Free Sample: https://reports.valuates.com/request/sample/ALLI-Auto-0E377/

Cell Therapy Market Share

Furthermore, increase in financing and investments to support launch of new companies is expected to boost organic revenue growth ofthe market. For instance, in July 2019, Bayer invested USD 215 Million for launch of Century Therapeutics, a U.S.-based biotechnology startup that aimed at developing therapies for solid tumors and blood cancer. Funding was further increased to USD 250 Billion by a USD 35 Mmillion contribution from Versant Ventures and Fujifilm Cellular Dynamics, which is anticipated to further boost the market growth.


Inception of effective guidelines for cell therapy manufacturing, development of advanced genomic analysis techniques, vast number of researches by cancer societies, and proven effectiveness of transplants are some of the primary growth factorsof the cell therapy market.According to the transplantation statistics 2019, in the U.S., each year, approximately 18,000 people, aged 0 to 74 years, benefit from a potentially life-saving bone marrow or umbilical cord blood transplant. Furthermore, Asia-Pacific exhibits high potential for growth in the market as it constituted around 4.60 billion of the global human population in 2019, which can serve as a potential patient base. Moreover, developing countries such as India and China are expected to experience growth, owing to surge in healthcare infrastructure, increase in affordability, and rise in awareness related to cell therapy.

View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0E377/cell-therapy

Key Companies
• ALLOSOURCE
• CELLS FOR CELLS
• HOLOSTEM TERAPIE AVANZATE SRL
• JCR PHARMACEUTICALS CO., LTD.
• KOLON TISSUEGENE, INC.
• MEDIPOST CO., LTD.
• MESOBLAST LTD
• NUVASIVE, INC.
• OSIRIS THERAPEUTICS, INC.
• STEMEDICA CELL TECHNOLOGIES, INC

Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/ALLI-Auto-0E377/

Similar Reports:

1. Bioinformatics Market: https://reports.valuates.com/market-reports/ALLI-Auto-0B326/bioinformatics

2. Organ On a Chip Market: https://reports.valuates.com/market-reports/QYRE-Auto-26C1860/global-organ-on-chip

3. Cell Culture Market: https://reports.valuates.com/reports/ALLI-Auto-1H413/cell-culture

4. Cell Analysis Market: https://reports.valuates.com/market-reports/QYRE-Auto-25Q1656/global-cell-analysis

5. Cell Separation Technologies Market: https://reports.valuates.com/reports/ALLI-Auto-1R429/cell-separation-technologies

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
To achieve a consistent view of the market, data is gathered from various primary and second

This release was published on openPR.